The Changing Epidemiology of the Herpes Virus: What Providers Need to Know
-
Register
- User - $25
This presentation will highlight the changing epidemiology of genital herpes simplex infections.
*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.
Credits: 1.0 contact hours; 0.33 are pharmacology
Expiration Date: December 31, 2024
$25
LEARNING OBJECTIVES
-Identify the clinical presentation of HSV I in the genitals
-Prescribe the appropriate pharmacologic medications for the treatment of HSV I in the genitals
-Educate patients about prevention of HSV acquisition in the genitals
Alison O. Marshall, RN, MSN, FNP-C
Faculty, Sylvie Ratelle STD/HIV Prevention Center of New England
Clinical Instructor, Boston College Connell School of Nursing
Alison Marshall is a board certified, practicing Family Nurse Practitioner (FNP). She earned her Bachelor of Arts (B.A.) in Sociology with Honors from Boston College in 2000, and her master’s in nursing from Yale University in 2005. She has completed her PhD coursework and is working on her dissertation, with expected graduation in 2024. Her research is focused on the connection between genital hair modification practices and the associated risk of acquiring sexually transmitted infections
Alison’s nursing practice is based in Massachusetts. She is a full-time Clinical Instructor at the Boston College Connell School of Nursing as well as Faculty at The Sylvie Ratelle STD/HIV Prevention Center of New England, a Centers for Disease Control (CDC) funded national training organization for practicing providers. Alison has practiced clinically at the South Boston Community Health Center since 2005
Alison lives happily in Cambridge, Massachusetts with her husband, daughter, and their French bulldog, Jarvis.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Courses/Certificates' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.00 contact hours, of which 0.33 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Alison Marshall, RN, MSN, FNP-C have disclosed no relevant financial relationships.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
